Indiva Net debt/EBITDA
Was ist das Net debt/EBITDA von Indiva?
Net debt/EBITDA von Indiva Ltd. ist -13.08
Was ist die Definition von Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA von Unternehmen in Health Care Sektor auf TSXV im Vergleich zu Indiva
Was macht Indiva?
Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Unternehmen mit net debt/ebitda ähnlich Indiva
- ECO Animal Health plc hat Net debt/EBITDA von -13.13
- Global Sweeteners hat Net debt/EBITDA von -13.12
- Taylor Devices hat Net debt/EBITDA von -13.09
- OSE Immunotherapeutics SA hat Net debt/EBITDA von -13.09
- Kamada Ltd hat Net debt/EBITDA von -13.09
- AM hat Net debt/EBITDA von -13.09
- Indiva hat Net debt/EBITDA von -13.08
- Echelon hat Net debt/EBITDA von -13.07
- Inseego hat Net debt/EBITDA von -13.05
- Cipher Pharmaceuticals hat Net debt/EBITDA von -13.05
- IXICO plc hat Net debt/EBITDA von -13.03
- Altair Engineering Inc hat Net debt/EBITDA von -13.00
- Avio S.p.A hat Net debt/EBITDA von -13.00